细胞培养市场规模、份额及成长分析（按应用、最终用户、产品及地区划分）－2026-2033年产业预测

2024 年全球细胞培养市场规模为 287.6 亿美元，预计到 2033 年将达到 796.2 亿美元，而 2025 年为 322 亿美元，在预测期（2026-2033 年）内复合年增长率为 11.98%。

由于细胞培养技术在製药和生物技术领域的重要应用，全球细胞培养市场正经历显着成长。推动这一增长的关键因素包括：慢性病和老龄化人口的增加，以及对先进治疗方案的需求不断增长，从而带动了生物製药需求的持续增长。细胞培养技术是生物製药生产的基础，尤其是在製药公司专注于标靶治疗和精准医疗的背景下。此外，将基于细胞的检测方法整合到药物筛检和研发中，也增强了药物发现能力。创新和持续的研发投入正在改变产业格局，而人们对细胞培养技术应用和技术进步的认识不断提高，也正在推动市场成长。北美和欧洲凭藉其强大的研究基础设施和对医疗保健领域的大量投资，在市场份额方面占据主导地位。

全球细胞培养市场按产品、应用、最终用户和地区进行细分。按产品划分，可分为耗材和设备。按应用划分，可分为生物製药生产、诊断、组织工程和再生医学、药物筛检和开发以及其他应用。按最终用户划分，可分为製药和生物技术公司、医院和诊断实验室、研究和学术机构以及其他最终用户。依地区划分，可分为北美、欧洲、亚太、拉丁美洲以及中东和非洲。

全球细胞培养市场驱动因素

全球细胞培养市场主要受生物製药领域持续创新的驱动。对包括单株抗体和疫苗在内的先进生物治疗方法的需求不断增长，对高效的细胞培养技术提出了更高的要求。随着生物製药产业积极拥抱精准医疗和标靶治疗，细胞培养对于这些复杂药物的生产至关重要，因此市场正在不断扩张。此外，尖端生物製程技术的整合、创新细胞培养基系统的开发以及用于改进生物药物生产的配套基础设施的建设，也都在促进这一增长，共同推动市场的发展。

全球细胞培养市场面临的限制因素

由于严格的监管要求和对高品质品管措施的需求，全球细胞培养市场面临许多挑战。生物製药和各种细胞产品的生产必须符合严格的安全性、有效性和一致性标准。这需要遵循良好生产规范 (GMP) 以及详尽的文件记录和检验流程。此外，对于市场参与企业，尤其是希望推出新产品的中小企业 (SME) 而言，应对复杂的监管合规流程可能尤其困难。这些障碍可能会抑制创新，并限制整个细胞培养产业的成长潜力。

全球细胞培养市场趋势

全球细胞培养市场的一个显着趋势是3D细胞培养技术的日益普及。与传统的2D培养相比，3D培养能够显着提高体外模型的生理相关性。这一转变的驱动力源于药物研发和个人化医疗领域对高预测性模型的日益增长的需求，研究人员希望更精确地模拟人体组织和疾病的复杂性。此外，生物材料和支架技术的进步也使得细胞生长和分化更有效率，进一步拓展了3D培养在製药、生物技术和再生医学领域的应用范围。最终，向3D培养的转变体现了业界对创新的执着追求和改善治疗效果的决心。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 案例研究

全球细胞培养市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 消耗品
  • 血清、培养基和试剂
  • 培养基
  • 试剂
  • 血清
  • 容器
  • 细胞培养系统/细胞堆
  • 滚轮/屋顶瓶
  • 烧瓶
  • 多孔孔盘
  • 培养皿
• 配件

全球细胞培养市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 生物製药生产
  • 单株抗体生产
  • 疫苗生产
  • 其他治疗性蛋白质的生产
• 诊断
• 组织工程与再生医学
  • 细胞和基因治疗
  • 其他组织工程及再生医学应用
• 药物筛检与开发
• 其他用途

全球细胞培养市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 医院和诊断检查室
• 研究和学术机构
• 其他最终用户

全球细胞培养市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.（US）
• Danaher Corporation（US）
• Merck KGAA（Germany）
• Sartorius AG（Germany）
• Corning Incorporated（US）
• Fujifilm Holdings Corporation（Japan）
• BD（Becton, Dickinson and Company）（US）
• Eppendorf SE（Germany）
• Lonza（Switzerland）
• Getinge AB（Sweden）
• Agilent Technologies, Inc.（US）
• Himedia Laboratories（India）
• Bio-Techne（US）
• Miltenyi Biotec（Germany）
• Stemcell Technologies（Canada）
• Solida Biotech GmbH（Germany）
• Caisson Labs Inc.（US）
• Promocell GmbH（Germany）
• Invivogen（US）
• Pan-Biotech（Germany）

结论与建议

Global Cell Culture Market size was valued at USD 28.76 Billion in 2024 and is poised to grow from USD 32.2 Billion in 2025 to USD 79.62 Billion by 2033, at a CAGR of 11.98% during the forecast period (2026-2033).

The global cell culture market is experiencing significant growth driven by its vital applications in pharmaceuticals and biotechnology. Key factors fueling this expansion include the increasing demand for biopharmaceuticals, driven by rising chronic diseases and an aging population, necessitating advanced therapeutic solutions. Cell culture serves as a cornerstone in biopharmaceutical manufacturing, particularly as pharmacological companies focus on targeted therapies and precision medicine. Furthermore, the integration of cell-based tests into drug screening and development enhances the capability for drug discovery. Innovation and ongoing R&D investments are transforming the landscape, while heightened awareness of cell culture applications and advancements in technology are propelling market growth. North America and Europe lead in contributions, backed by robust research infrastructures and substantial health sector investments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Market Segments Analysis

The global cell culture market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Equipment. Based on Application, the market is segmented into Biopharmaceutical Production, Diagnostics,Tissue Engineering& Regenerative Medicine, Drug Screening & Development, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Culture Market

The global cell culture market is significantly propelled by continuous innovations within the biopharmaceutical sector. The growing demand for advanced biotherapies, including monoclonal antibodies and vaccines, necessitates efficient cell culture techniques. As the biopharmaceutical industry embraces precision medicine and targeted therapies, the market expands due to the reliance on cell culture for the production of these complex drugs. Additionally, the integration of cutting-edge bioprocessing technologies and the development of innovative cell culture media systems contribute to this growth, as do supportive infrastructures aimed at enhancing the production of biological pharmaceuticals, collectively driving the market's upward trajectory.

Restraints in the Global Cell Culture Market

The Global Cell Culture market faces considerable challenges due to strict regulatory requirements and the necessity for high-quality control measures. The production of biopharmaceuticals and various cell-based products must adhere to stringent safety, efficacy, and consistency standards. This compliance requires extensive documentation and validation processes, along with adherence to Good Manufacturing Practices (GMP). Moreover, navigating the complexities of regulatory compliance can be particularly daunting for market participants, especially smaller companies seeking to introduce new products. These hurdles hinder innovation and may limit the overall growth potential within the cell culture sector.

Market Trends of the Global Cell Culture Market

A notable trend in the global cell culture market is the increasing adoption of 3D cell culture technologies, which enhance the physiological relevance of in vitro models compared to traditional 2D cultures. This shift is driven by the growing demand for more predictive models in drug development and personalized medicine, as researchers seek to better mimic the complexities of human tissues and diseases. Additionally, advancements in biomaterials and scaffolding techniques are facilitating more effective cell growth and differentiation, further expanding applications across pharmaceuticals, biotechnology, and regenerative medicine. Ultimately, the move towards 3D cultures reflects the industry's commitment to innovation and improved therapeutic outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Case Studies

Global Cell Culture Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Sera, Media, And Reagents
  • Media
  • Reagents
  • Sera
  • Vessels
  • Cell factory systems/cell stacks
  • Roller/roux bottles
  • Flasks
  • Multiwell plates
  • Petri dishes
• Accessories

Global Cell Culture Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Production
  • Monoclonal Antibody Production
  • Vaccine Production
  • Other Therapeutic Protein Production
• Diagnostics
• Tissue Engineering & Regenerative Medicine
  • Cell & Gene Therapy
  • Other Tissue Engineering & Regenerative Medicine Applications
• Drug Screening & Development
• Other Applications

Global Cell Culture Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

Global Cell Culture Market Size & CAGR (2026-2033)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solida Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caisson Labs Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promocell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invivogen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pan-Biotech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations